238 related articles for article (PubMed ID: 35997336)
21. Polyamine homeostasis-based strategies for cancer: The role of combination regimens.
Li QZ; Zuo ZW; Zhou ZR; Ji Y
Eur J Pharmacol; 2021 Nov; 910():174456. PubMed ID: 34464603
[TBL] [Abstract][Full Text] [Related]
22. The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines.
Stanic' I; Facchini A; Borzì RM; Stefanelli C; Flamigni F
J Cell Physiol; 2009 Apr; 219(1):109-16. PubMed ID: 19097065
[TBL] [Abstract][Full Text] [Related]
23. Polyamine metabolism in a member of the phylum Microspora (Encephalitozoon cuniculi): effects of polyamine analogues.
Bacchi CJ; Rattendi D; Faciane E; Yarlett N; Weiss LM; Frydman B; Woster P; Wei B; Marton LJ; Wittner M
Microbiology (Reading); 2004 May; 150(Pt 5):1215-1224. PubMed ID: 15133083
[TBL] [Abstract][Full Text] [Related]
24. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives.
Seiler N
Curr Drug Targets; 2003 Oct; 4(7):565-85. PubMed ID: 14535655
[TBL] [Abstract][Full Text] [Related]
25. Polyamine Homeostasis in Development and Disease.
Nakanishi S; Cleveland JL
Med Sci (Basel); 2021 May; 9(2):. PubMed ID: 34068137
[TBL] [Abstract][Full Text] [Related]
26. Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157.
Shao D; Xiao L; Ha HC; Casero RA
J Cell Physiol; 1996 Jan; 166(1):43-8. PubMed ID: 8557774
[TBL] [Abstract][Full Text] [Related]
27. Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy.
Xie Y; Murray-Stewart T; Wang Y; Yu F; Li J; Marton LJ; Casero RA; Oupický D
J Control Release; 2017 Jan; 246():110-119. PubMed ID: 28017891
[TBL] [Abstract][Full Text] [Related]
28. The role of polyamines in gastric cancer.
McNamara KM; Gobert AP; Wilson KT
Oncogene; 2021 Jul; 40(26):4399-4412. PubMed ID: 34108618
[TBL] [Abstract][Full Text] [Related]
29. Polyamine metabolism-based dual functional gene delivery system to synergistically inhibit the proliferation of cancer.
Cui PF; Xing L; Qiao JB; Zhang JL; He YJ; Zhang M; Lyu JY; Luo CQ; Jin L; Jiang HL
Int J Pharm; 2016 Jun; 506(1-2):79-86. PubMed ID: 27102990
[TBL] [Abstract][Full Text] [Related]
30. A perspective of polyamine metabolism.
Wallace HM; Fraser AV; Hughes A
Biochem J; 2003 Nov; 376(Pt 1):1-14. PubMed ID: 13678416
[TBL] [Abstract][Full Text] [Related]
31. Chromatin remodeling by polyamines and polyamine analogs.
Pasini A; Caldarera CM; Giordano E
Amino Acids; 2014 Mar; 46(3):595-603. PubMed ID: 23836422
[TBL] [Abstract][Full Text] [Related]
32. A putrescine-anthracene conjugate: a paradigm for selective drug delivery.
Palmer AJ; Ghani RA; Kaur N; Phanstiel O; Wallace HM
Biochem J; 2009 Dec; 424(3):431-8. PubMed ID: 19811451
[TBL] [Abstract][Full Text] [Related]
33. Targeting polyamine transport in Trypanosoma cruzi.
Reigada C; Phanstiel O; Miranda MR; Pereira CA
Eur J Med Chem; 2018 Mar; 147():1-6. PubMed ID: 29421567
[TBL] [Abstract][Full Text] [Related]
34. Regulation of polyamine transport by polyamines and polyamine analogs.
Kramer DL; Miller JT; Bergeron RJ; Khomutov R; Khomutov A; Porter CW
J Cell Physiol; 1993 May; 155(2):399-407. PubMed ID: 8482732
[TBL] [Abstract][Full Text] [Related]
35. Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.
Akinyele O; Wallace HM
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067619
[TBL] [Abstract][Full Text] [Related]
36. Ant 4,4, a polyamine-anthracene conjugate, induces cell death and recovery in human promyelogenous leukemia cells (HL-60).
Traquete R; Ghani RA; Phanstiel O; Wallace HM
Amino Acids; 2013 Apr; 44(4):1193-203. PubMed ID: 23292094
[TBL] [Abstract][Full Text] [Related]
37. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.
Casero RA; Marton LJ
Nat Rev Drug Discov; 2007 May; 6(5):373-90. PubMed ID: 17464296
[TBL] [Abstract][Full Text] [Related]
38. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
Aziz SM; Gillespie MN; Crooks PA; Tofiq SF; Tsuboi CP; Olson JW; Gosland MP
J Pharmacol Exp Ther; 1996 Jul; 278(1):185-92. PubMed ID: 8764350
[TBL] [Abstract][Full Text] [Related]
39. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
[TBL] [Abstract][Full Text] [Related]
40. Unusual aspects of the polyamine transport system affect the design of strategies for use of polyamine analogues in chemotherapy.
Mitchell JL; Thane TK; Sequeira JM; Thokala R
Biochem Soc Trans; 2007 Apr; 35(Pt 2):318-21. PubMed ID: 17371269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
